Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free REVBW Stock Alerts

Revelation Biosciences (REVBW) Competitors

$0.01 0.00 (-1.65%)
Closing price 05/29/2026 03:58 PM Eastern
Extended Trading
$0.01 +0.00 (+15.13%)
As of 05/29/2026 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

REVBW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Revelation Biosciences stock or one of its competitors? MarketBeat compares Revelation Biosciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Revelation Biosciences include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Revelation Biosciences compare to Ainos?

Revelation Biosciences (NASDAQ:REVBW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

In the previous week, Revelation Biosciences and Revelation Biosciences both had 2 articles in the media. Revelation Biosciences' average media sentiment score of 1.44 beat Ainos' score of 0.44 indicating that Revelation Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Revelation Biosciences Positive
Ainos Neutral

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
Ainos N/A N/A N/A

Summary

Revelation Biosciences and Ainos tied by winning 1 of the 2 factors compared between the two stocks.

How does Revelation Biosciences compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Revelation Biosciences (NASDAQ:REVBW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Revelation BiosciencesN/AN/AN/AN/AN/A

In the previous week, Alvotech and Alvotech both had 2 articles in the media. Alvotech's average media sentiment score of 1.44 equaled Revelation Biosciences'average media sentiment score.

Company Overall Sentiment
Alvotech Positive
Revelation Biosciences Positive

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Revelation Biosciences N/A N/A N/A

Summary

Alvotech beats Revelation Biosciences on 1 of the 1 factors compared between the two stocks.

How does Revelation Biosciences compare to Aravive?

Aravive (NASDAQ:ARAV) and Revelation Biosciences (NASDAQ:REVBW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Revelation BiosciencesN/AN/AN/AN/AN/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Revelation Biosciences had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for Revelation Biosciences and 0 mentions for Aravive. Revelation Biosciences' average media sentiment score of 1.44 beat Aravive's score of 0.00 indicating that Revelation Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Revelation Biosciences Positive

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Revelation Biosciences N/A N/A N/A

Summary

Aravive and Revelation Biosciences tied by winning 2 of the 4 factors compared between the two stocks.

How does Revelation Biosciences compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Revelation Biosciences (NASDAQ:REVBW) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

In the previous week, Revelation Biosciences had 2 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 2 mentions for Revelation Biosciences and 0 mentions for Atlantic Coastal Acquisition Corp. II. Revelation Biosciences' average media sentiment score of 1.44 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Revelation Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Revelation Biosciences Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Revelation BiosciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Revelation Biosciences N/A N/A N/A

Summary

Revelation Biosciences beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Revelation Biosciences compare to Biofrontera?

Revelation Biosciences (NASDAQ:REVBW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

In the previous week, Revelation Biosciences and Revelation Biosciences both had 2 articles in the media. Revelation Biosciences' average media sentiment score of 1.44 beat Biofrontera's score of 0.43 indicating that Revelation Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Revelation Biosciences Positive
Biofrontera Neutral

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Summary

Revelation Biosciences and Biofrontera tied by winning 1 of the 2 factors compared between the two stocks.

Get Revelation Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for REVBW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding REVBW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

REVBW vs. The Competition

Export
MetricRevelation BiosciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$388.04M$55.95B$30.05B
Dividend YieldN/A3.86%2.69%5.33%
P/E RatioN/A3.0721.6326.26
Price / SalesN/A7,203.00565.57116.86
Price / CashN/A13.1343.2256.84
Price / BookN/A85.4810.557.30
Net IncomeN/A-$96.07M$3.56B$337.27M
7 Day PerformanceN/A2.02%2.85%3.58%
1 Month PerformanceN/A2.87%4.59%5.71%
1 Year PerformanceN/A96.23%37.62%39.70%

Revelation Biosciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
REVBW
Revelation Biosciences
N/A$0.01
-1.7%		N/A+4.4%$0.00N/AN/A10
AIMDW
Ainos
N/A$0.12
-1.6%		N/A-21.5%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.27
+49.8%		N/A-88.0%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
-35.3%		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:REVBW) was last updated on 5/31/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel